Drug Database
Back to search

Belgium· BE-AMP-SAM236932-00

Zonavir 125 mg

A brivudine product containing brivudine, registered in Belgium by Laboratori Guidotti. The same ATC class is registered in 6 of our 19 countries.

ATC J05AB15

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedZonavir 125 mgATCJ05AB15REGISTER NO.BE-AMP-SAM236932-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about brivudineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Brivudine is registered in 6 of 19 countries.

Countries holding a registration under ATC J05AB15 (brivudine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose
Search brivudine products by name

Brivudine · ATC J05AB15

6 / 19 countries

  • Belgiumprice
  • Germany
  • Italyprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of brivudine costs, country by country.

Normalised to the WHO defined daily dose (0.125 g), the median price runs from $7.99 in Italy to $12.58 in Switzerland — a ×1.6 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Brivudine · price per daily dose (0.125 g)

USD · FX 28 Sept 2026

  • CH Switzerland$12.58
  • ES Spain$10.83
  • IT Italy$7.99
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Brivudine
Manufacturer
Laboratori Guidotti
Country
Belgium (BE)
ATC code
J05AB15
ATC class
Brivudine
Defined daily dose
0.125 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    2678480

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for brivudine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check brivudine against other medicinesHow interaction checks work

Brivudine · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Brivudine in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All brivudine products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Austria · Brivudin Aristo, Mevir
  • Germany · Brivudin Aristo, Premovir
  • Spain · Brivudina Aristo, Nervinex
  • Greece · Brivir
  • Italy · Brivirac, Brivudina Aristo
  • Portugal · Bridic
  • Romania · Brival
  • Slovenia · Premovir
  • Slovakia · Zovudex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c103a6cf-8d88-4a4d-ba1b-aaaaf7c6f6b5
GET /v1/drugs/c103a6cf-8d88-4a4d-ba1b-aaaaf7c6f6b5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Zonavir 125 mg",
  "name_fr": "Zonavir 125 mg",
  "name_nl": "Zonavir 125 mg",
  "amp_code": "SAM236932-00",
  "strengths": [
    "125.0000",
    "125.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Brivudine"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Brivudine",
  "authorisation_numbers": [
    "BE236932"
  ]
}
API referenceMCP serverPlans

See everything about brivudine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console